OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Cannabinoids and the endocannabinoid system in anxiety, depression, and dysregulation of emotion in humans
Verity Chadwick, Cathrin Rohleder, Dagmar Koethe, et al.
Current Opinion in Psychiatry (2019) Vol. 33, Iss. 1, pp. 20-42
Closed Access | Times Cited: 55

Showing 1-25 of 55 citing articles:

Treatment of Posttraumatic Stress Disorder: A State-of-the-art Review
Lisa Burback, Suzette Brémault‐Phillips, Mirjam J. Nijdam, et al.
Current Neuropharmacology (2023) Vol. 22, Iss. 4, pp. 557-635
Closed Access | Times Cited: 96

Endocannabinoid System and Exogenous Cannabinoids in Depression and Anxiety: A Review
Ahmed Hasbi, Bertha K. Madras, Susan R. George
Brain Sciences (2023) Vol. 13, Iss. 2, pp. 325-325
Open Access | Times Cited: 38

Cannabidiol and its Potential Evidence-Based Psychiatric Benefits – A Critical Review
Inga Dammann, Cathrin Rohleder, F. Markus Leweke
Pharmacopsychiatry (2024) Vol. 57, Iss. 03, pp. 115-132
Closed Access | Times Cited: 13

Cannabis use and mood disorders: a systematic review
Maryam Sorkhou, Eliza L Dent, Tony P. George
Frontiers in Public Health (2024) Vol. 12
Open Access | Times Cited: 9

Cannabinoid CB1 Receptor Involvement in the Actions of CBD on Anxiety and Coping Behaviors in Mice
Amaya Austrich-Olivares, María S. García‐Gutiérrez, Lucía Illescas, et al.
Pharmaceuticals (2022) Vol. 15, Iss. 4, pp. 473-473
Open Access | Times Cited: 34

Modulation of Endocannabinoid System Components in Depression: Pre-Clinical and Clinical Evidence
Uri Bright, Irit Akirav
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 10, pp. 5526-5526
Open Access | Times Cited: 29

Cannabidiol induces antidepressant and anxiolytic‐like effects in experimental type-1 diabetic animals by multiple sites of action
Yane Costa Chaves, Karina Genaro, José Alexandre S. Crippa, et al.
Metabolic Brain Disease (2021) Vol. 36, Iss. 4, pp. 639-652
Closed Access | Times Cited: 40

Bipolar Disorder and Comorbid Use of Illicit Substances
Ulrich W. Preuss, Martin Schaefer, Christoph Born, et al.
Medicina (2021) Vol. 57, Iss. 11, pp. 1256-1256
Open Access | Times Cited: 38

The role of cannabinoid-mediated signaling pathways and mechanisms in brain disorders
Shunfeng Liu, Zegang Ma
Cellular Signalling (2025), pp. 111653-111653
Closed Access

Optimization of seizure prevention by cannabidiol (CBD)
Bidhan Bhandari, Sahar Emami Naeini, Sholeh Rezaee, et al.
Translational Neuroscience (2025) Vol. 16, Iss. 1
Open Access

A Systematic Review of Cannabis and Anxiety: Chicken or Egg?
Lily G. Blyth, Chris J. Seal, Maryam Sorkhou, et al.
Current Addiction Reports (2025) Vol. 12, Iss. 1
Closed Access

FAAH Inhibition Restores Early Life Stress-Induced Alterations in PFC microRNAs Associated with Depressive-Like Behavior in Male and Female Rats
Anna Portugalov, Hiba Zaidan, Inna Gaisler‐Salomon, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 24, pp. 16101-16101
Open Access | Times Cited: 18

The Role of the Endocannabinoid System in Binge Eating Disorder
Romain Bourdy, Katia Befort
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 11, pp. 9574-9574
Open Access | Times Cited: 10

Discovery of a CB2 and 5-HT1A receptor dual agonist for the treatment of depression and anxiety
Wenjiao Yang, Xudong Gong, Haiguo Sun, et al.
European Journal of Medicinal Chemistry (2023) Vol. 265, pp. 116048-116048
Closed Access | Times Cited: 9

Gastrodin Ameliorates Post-Stroke Depressive-Like Behaviors Through Cannabinoid-1 Receptor-Dependent PKA/RhoA Signaling Pathway
Shiquan Wang, Liang Yu, Haiyun Guo, et al.
Molecular Neurobiology (2024)
Closed Access | Times Cited: 3

Recent advances in the understanding of the aetiology and therapeutic strategies in burning mouth syndrome: Focus on the actions of cannabinoids
Sónia R. Pereira, Johana Tello Velasquez, Sarah Duggan, et al.
European Journal of Neuroscience (2020) Vol. 55, Iss. 4, pp. 1032-1050
Open Access | Times Cited: 19

Repurposing Cannabidiol as a Potential Drug Candidate for Anti-Tumor Therapies
Fei Wang, Gabriele Multhoff
Biomolecules (2021) Vol. 11, Iss. 4, pp. 582-582
Open Access | Times Cited: 17

Weeding Out the Stigma: Older Veterans in Illinois Share Their Experiences Using Medical Cannabis
Kelly Lynn Clary, Hyojung Kang, Laura Quintero Silva, et al.
Journal of Psychoactive Drugs (2022) Vol. 55, Iss. 3, pp. 274-281
Closed Access | Times Cited: 11

Augmented anandamide signalling in the substantia nigra pars reticulata mediates panicolytic-like effects in mice confronted by Crotalus durissus terrificus pit vipers
Rafael Carvalho Almada, Luiz Luciano Falconi‐Sobrinho, Juliana A. da Silva, et al.
Psychopharmacology (2022) Vol. 239, Iss. 9, pp. 2753-2769
Closed Access | Times Cited: 10

Tai Chi exercise reduces circulating levels of inflammatory oxylipins in postmenopausal women with knee osteoarthritis: results from a pilot study
Chwan‐Li Shen, John W. Newman, Moamen M. Elmassry, et al.
Frontiers in Medicine (2023) Vol. 10
Open Access | Times Cited: 6

Mechanisms of repetitive transcranial magnetic stimulation for anti-depression: Evidence from preclinical studies
Di Luan, Mingge Zhao, Yachen Shi, et al.
World Journal of Psychiatry (2020) Vol. 10, Iss. 10, pp. 223-233
Open Access | Times Cited: 15

Page 1 - Next Page

Scroll to top